MedTrace Logo

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

NCT00136110 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2007-05-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether the use of sodium valproate is effective in slowing the disease progression in Amyotrophic Lateral Sclerosis.

Conditions

Interventions

DRUG

Sodium Valproate

Sponsors & Collaborators

  • Princess Beatrix Muscle Foundation

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Leonard H Van den Berg, MD, PhD · UMC Utrecht

  • Sanne Piepers, MD · UMC Utrecht

  • Sonja W De Jong, MD · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2007-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00136110 on ClinicalTrials.gov